The trademark application FRENAXSIN was filed by Johnson & Johnson, a U.S. corporation (the "Applicant"). The application was published for oppositions on June 9, 2021, and it was registered by office on September 16, 2021 without any oppositions.
The application was filed in English (German was selected as the second language).